Data Insights
By Company Name
No filters selected
By Disease Name
No filters selected
By Drug Name
No filters selected
By Themes
No filters selected
Showing 1 results out of 1
Data Insights
Tilpisertib fosmecarbil by Gilead Sciences for Ulcerative Colitis: Likelihood of Approval
Tilpisertib fosmecarbil is under clinical development by Gilead Sciences and currently in Phase II for Ulcerative Colitis. According to GlobalData,...